Top 5 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying

4. Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) has been in Sphera Global’s portfolio since early 2020 and the fund bought another 203,416 shares of the company during Q3. Those additions gave the fund 750,603 shares overall and a 1.52% ownership stake in the company as of September 30. Sphera Global was one of many hedge funds to take a stake in SNDX during 2020, as hedge fund ownership of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) more than tripled during the year, similar to the surge in the stock’s share price.

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)’s SNDX-5613 for the treatment of critical leukemia in adult and pediatric patients, was granted orphan drug designation in Europe towards the end of last year, following in the footsteps of its fast track designation by the FDA in June. Syndax is well positioned, with a cash runway that extends into early 2024 and having a commercialization collaboration in place with Incyte Corporation (NASDAQ:INCY).